News
Cronos Group Reports Q3 2025 Financial Results
TORONTO – Cronos Group Inc., a Canadian Cannabis producer with a growing international footprint, reported third-quarter results that marked new highs for revenue, profitability, and cash reserves, even as domestic challenges in Canada tempered some gains. The company posted net revenue of $36.3 million for the period, up 6% from the prior year and 9% ...
Aurora Cannabis Reports Q2 FY2026 Financial Results
EDMONTON – Aurora Cannabis Inc. posted a solid second quarter for its fiscal 2026, with total net revenue climbing 11% to CA$90.4 million, driven by a surge in international medical Cannabis sales that highlighted the company's shift away from lower-margin consumer markets. The results, covering the three months ended September 30, 2025, showed global medical ...
Cresco Labs Reports Q3 2025 Financial Results
CHICAGO – Cresco Labs, a major player in branded Cannabis products and the Sunnyside retail chain, announced third-quarter results showing revenue of $165 million for the period ended September 30. The figure marked a modest sequential increase from the prior quarter, even as the company absorbed costs from a recent debt overhaul. Operating cash flow ...
Planet 13 Exits California, Focusing on Nevada and Florida
LAS VEGAS – Planet 13 Holdings Inc., the vertically integrated Cannabis operator known for its expansive Las Vegas flagship, disclosed plans this week to sell off its sole California retail outlet and shutter its cultivation operation there, signaling a deliberate shift toward its primary strongholds. The moves involve transferring the company's Orange County dispensary license ...
Green Thumb Industries Reports Q3 2025 Financial Results
CHICAGO – Green Thumb Industries released third-quarter earnings that reflected a narrow sales increase alongside deepening price cuts in established markets. The company posted $291.4 million in revenue for the period, a 1.6% rise from the year-earlier figure, falling just shy of Wall Street's $296 million forecast. That growth stemmed largely from an 8% jump ...
Curaleaf Reports Q3 2025 Financial Results
STAMFORD – Curaleaf Holdings Inc. unveiled its third-quarter financials, revealing a revenue figure that edged past analyst forecasts while underscoring the company's deepening reliance on global markets to counter domestic challenges. The Cannabis MSO recorded net revenue of $320 million for the three months ended September 30, surpassing expectations by a slim margin and climbing ...
Mamdani’s Mayoral Win: Is It a Sign of Equity in NY’s Cannabis Field?
LOS ANGELES – New York City's mayoral race concluded with Zohran Mamdani's clear mandate on November 4, 2025, as the 34-year-old assemblyman secured 50.4% of the vote against former Gov. Andrew Cuomo's 41.6% and Curtis Sliwa's over 7%, with turnout hitting 62% – the highest in two decades for a non-presidential year. This triumph installed ...
Alcohol Giants Press Congress to Outlaw Intoxicating Hemp Derivatives
WASHINGTON – In a letter sent Tuesday, a coalition of leading alcohol trade groups urged congressional leaders to suspend sales of intoxicating hemp-derived products until federal rules can be established, warning that the market's unchecked growth endangers consumers and violates existing law. The American Distilled Spirits Alliance, Beer Institute, Distilled Spirits Council of the United ...
Trulieve Reports Q3 2025 Financial Results
TALLAHASSEE – Trulieve Cannabis Corp. disclosed third-quarter results showing revenue of $288 million, edging up 1% from the year-ago period but dipping 5% from the second quarter. The figures highlight a push toward tighter operations and liquidity in a fragmented industry, with the company ending the period with $458 million in cash. Gross profit stood ...
Trulieve Redeems $368M in Notes, Signaling Debt Reduction Push
TALLAHASSEE – Trulieve Cannabis Corp. has announced its decision to redeem its entire $368 million portfolio of 8.0% senior secured notes, due in 2026. The company issued the redemption notice, setting an early payoff date of December 4 at 100% of the principal plus accrued interest, according to a filing with the Securities and Exchange ...
Jushi Holdings Reports Q3 2025 Financial Results
LOS ANGELES – Jushi Holdings Inc., a vertically integrated Cannabis operator with footprints in six states, disclosed third-quarter 2025 financials that showed revenue climbing 6.6% year-over-year to $65.7 million, driven by higher wholesales and customer traffic at its dispensaries. Gross profit climbed to $30.7 million, lifting the margin to 46.7% [a 125 basis-point improvement year-over-year ...
Compass Pathways Advances Psilocybin Therapy Timeline for Depression Treatment
LONDON & NEW YORK – Compass Pathways reported Q3 2025 financial results and signaled a faster path to market for its lead psilocybin-based therapy in treatment-resistant depression (TRD). The biotechnology firm now targets commercialization readiness 9 to 12 months ahead of schedule, a shift driven by completed enrollment in its second Phase 3 trial and ...
Missouri Trade Group Report Finds 96% of Tested Hemp Products Exceed THC Thresholds
KANSAS CITY – A new investigation by the Missouri Cannabis Trade Association (MoCannTrade) has concluded that nearly all hemp-derived products sold at unregulated retailers in the state contain illegal levels of THC, raising questions about consumer safety and market oversight in the $1.2 billion U.S. hemp sector. The report, titled Missouri Hemp Hoax, details testing ...
New Mexico Cannabis Market Edges Toward $2B in Total Sales
ALBUQUERQUE – New Mexico's Cannabis industry has recorded $1.9 billion in combined medical and adult-use sales since recreational legalization took effect in April 2022, according to the latest figures from the state’s Regulation and Licensing Department. With two months left in the year, the market stands just $68 million short of the $2 billion threshold, ...
Fairfax Bank Retreats from Servicing Cannabis Businesses
FAIRFAX – MainStreet Bancshares Inc., a community lender with $2.2 billion in assets, has shelved its Cannabis banking program just eight months after unveiling it as a growth driver. The decision, disclosed by CEO Jeff Dick, aims to broaden the bank's appeal to prospective acquirers wary of federal restrictions on Cannabis-related services. The retreat marks ...
Stiiizy Halts Sales at Catalyst Outlets as Leadership Clash Deepens
LOS ANGELES – Stiiizy, California's dominant Cannabis brand with a footprint in Arizona, Michigan, and Nevada, has stopped supplying its products to Catalyst Cannabis Co. stores, marking a sharp break in what was once a key retail partnership. The move, confirmed by Stiiizy, stems from ongoing friction between the companies' leadership teams. The decision affects ...
Arizona Funds Nation’s First Whole-Mushroom Psilocybin Trial Targeting PTSD in Veterans & First Responders
PHOENIX – State officials in Arizona have authorized and financed what amounts to the country's initial controlled study of whole psilocybin mushrooms as a treatment for post-traumatic stress disorder (PTSD) among police officers, firefighters, and military veterans, marking a significant step forward in regulated psychedelic research. The trial, set to begin in November, will enroll ...
Bioxyne Reports Record Revenue, Yet Cash Outflows Climb on Expansion Push
SYDNEY – Bioxyne Limited, an Australian life sciences and wellness products company, posted its highest quarterly revenue on record for the period ended September 30, with sales reaching A$14.1 million, a 210% jump from the prior-year quarter and 47% above the previous three months. The results signal robust demand in Europe and the United Kingdom, ...
Kansas Poll Shows Broad Support for Cannabis Reform
TOPEKA – A recent survey of Kansas residents highlights growing public enthusiasm for Cannabis policy changes, with nearly seven in ten adults endorsing medical use and close to six in ten favoring recreational access. A Kansas Speaks Fall 2025 report released by the Docking Institute of Public Affairs at Fort Hays State University captured the ...
Cybin Raises $175M in Direct Offering, Reinforcing Psychedelic Pipeline
TORONTO – Cybin Inc., a clinical-stage biopharmaceutical company focused on psychedelic-based treatments for mental health disorders, disclosed a $175 million registered direct offering, drawing commitments from a roster of established biotech investors. The deal, priced at $6.51 per share or pre-funded warrant, stands as the biggest capital infusion in the psychedelics field [!] this year, ...
MariMed Steps Away from Missouri Operations
NORWOOD – In a sharp turn from expansion plans, MariMed Inc. announced it is shutting down its Missouri operations, ending a yearlong effort to build a foothold in the state's burgeoning recreational market and opting instead to channel investments into states where it already holds solid ground. The decision, detailed in a company statement, marks ...
Lebanon Legalizes Cannabis, Forms Oversight Body, Targeting $1B in Annual Revenue
BEIRUT – In a significant step forward in leveraging its Cannabis sector for economic relief, the Lebanese government established a dedicated committee to regulate the cultivation and sales of Cannabis under a long-dormant 2020 law. The move could channel up to $1 billion yearly into the state treasury, according to projections from McKinsey & Company. ...
Verano Shareholders Approve Corporate Home Relocation to Nevada
CHICAGO – Verano Holdings Corp. secured strong backing from investors to move its parent company's legal base from British Columbia, Canada, to Nevada. The approval came during a special shareholder meeting, clearing a key hurdle in the company's effort to align its structure more closely with its American operations. The vote passed with broad support, ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Executives and operators in the Cannabis and psychedelics sectors wrapped up another fortnight with a mix of regulatory headwinds, financial maneuvers, and market validations that underscore the sector's resilience. From bipartisan efforts to safeguard youth exposure to breakthroughs in debt management and explosive sales in new recreational states, these developments reveal a ...
MariMed Strikes Licensing Deal to Bring Edibles Line to New York Market
NORWOOD – MariMed Inc. has signed a licensing agreement with Farm 2 Hand, LLC, a licensed cultivator and processor in New York, to roll out its lineup of edibles across the state starting in 2026. Under the pact, Farm 2 Hand will handle manufacturing and distribution for MariMed's key brands, including Betty’s Eddies fruit chews, ...
